Latest filing published 30 Aug 2024 for Novonesis (Novozymes A/S), €150k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Maha Kutay: trading record in brief
All filings by Maha Kutay on record concern Novonesis (Novozymes A/S). In total, 2 filings cover trades dated from 28 October 2021 to 30 August 2024.
Purchases make up the whole of the open-market record (2 purchases, €162k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2024, the count stands at 1 purchase and no sales.
The latest filing, published on 30 August 2024, reports an open-market purchase of €150k in Novonesis (Novozymes A/S). These figures are compiled from regulatory filings published by Finanstilsynet DK. They describe what insiders did and are not a recommendation.
Companies and markets linked to Maha Kutay
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,400 shares@ DKK 466.650.0% of flowShareBEUP, AQED, CEUDISIN DK0060336014DK:1313914Canonical exit: 28 Nov 2024 (T+90)
- 186 shares@ DKK 468.30010.0000% mcap0.0% of flowShareISIN DK0060336014DK:1122075Canonical exit: 26 Jan 2022 (T+90)
2 of 2 declarations